Developmental Research Program
Developmental Research Program
批准号:
7727540
负责人:
MARTIN MCINTOSH
金额:
$7.23万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-01 至 2014-06-30
关键词:
AddressAreaAwardBudgetsClinicalCollaborationsComplementDataDecision MakingDevelopmentDiseaseFred Hutchinson Cancer Research CenterFundingGoalsImmunologyImmunotherapyIncidenceLaboratoriesLeadershipLettersMalignant neoplasm of ovaryMedical ResearchMolecular BiologyMolecular ProfilingNatureOutcomeOvarianOvaryPeer ReviewPopulationProcessProgram Research Project GrantsPublic HealthReproduction sporesResearchResearch PersonnelResearch Project GrantsResearch ProposalsResearch SupportResourcesRisk AssessmentRoleScienceScientistSpecimenStagingSummary ReportsSystemTechnologyTranslational ResearchWorkanticancer researchbasecostdesignflexibilityimprovedmeetingsnew technologynovelpopulation basedprogramsprospectiveresearch studytool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
As described in the Leadership and Administration Core, an interdisciplinary group of senior leaders is available to interact with each other on a variety of substantive committees - two of which serve to evaluate developmental research studies and guide decision making on the use of stored specimens or the collecfion of prospective specimens needed to conduct these studies. In this section of the SPORE proposal we describe the allocafion of SPORE resources to DRP projects. There are four kinds of SPORE resources: funding to support the research costs of developmental studies, access to stored specimens for use in developmental studies, access to a pafient population with the potenfial to collect prospective specimens to support developmental studies, and data describing prior characterizafion of banked annotated specimens. In recognifion of rapidly changing technology and new and novel applications of such technology for research,
approximately $176,000 in total costs will be available per year in the Developmental Research Program (DRP) budget. Matching insfitufional funds from Fred Hutchinson Cancer Research Center (FHCRC) will be available at the discrefion ofthe PI for outstanding ovarian SPORE developmental research projects that address SPORE priorifies in risk assessment and early detecfion, immunotherapy, molecular signatures, and development of novel treatments of ovarian cancer (see FHCRC letter of institufional commitment).
Through early detecfion we hope to improve outcomes significanfiy, because 1) currently available treatments are more effective in disease confined to the ovary, and 2) we will develop novel, relatively non-toxic treatments that will be particularly effective in early-stage disease. The tools of molecular biology, immunology and immunotherapy are emphasized in the translational research program. The POCRC is a communitybased, mulfidisciplinary, translafional research program that involves clinicians, laboratory scienfists and public health scientists from several research and medical insfitufions in the region. The broad based approach takes full advantage ofthe scientific expertise available locally and allows the pooling of clinical resources, thus facilitafing population-based studies despite the low incidence of ovarian cancer.
Applications will be solicited annually for use of these funds, and each applicafion will be reviewed for its scientific merit and its resource needs including access to specimens. This secfion of the SPORE application oufiines the POCRC's system for evaluafion of developmental research study applicafions and progress. It also includes a summary report on previously funded or on-going projects, as well as several examples of projects
that might be inifiated next year if funding is available.
Dr. Martin Mcintosh, program leader, will oversee this program and the Executive Committee will evaluate the
progress ofthe funded developmental research studies. This program has, and will continue to be, flexible in
nature and funding priorities will change according to scientific needs ofthe overall program. Excifing
laboratory science with translafional potenfial is a high priority. DRP applicafions should be designed to
develop within a couple years into full-scale translafional research projects suitable for a SPORE or ROI
applicafion. As collaboration between a laboratory, clinical and/or public health scienfist greafiy facilitates
translational research, DRP projects are usually co-directed by an interdisciplinary team of two invesfigators.
Inclusion of a POCRC/SPORE investigator as a co-director facilitates integrafion with SPORE themes and
appropriate use of the SPORE core resources.
Since 1999, the POCRC DRP has funded 29 developmental research proposals with approximately $1.5
million in total funding support. A total of 66 applications have been reviewed, for a funding rate of 44%. We
vvill continue to use the current peer-review process to select new projects to be supported by SPORE
resources, as it has been very successful.. SPORE funds have been awarded to highly meritorious applicants
proposing studies that complement on-going POCRC projects and meet translafional research criteria each
year. Six of the DRP awards have led to new projects (Projects 4 and 5) or new roles in the next funding
period for an invesfigator (Tewari, Swisher, Salazar, and Knudsen). DRP funds have been used to grow new
scientific projects and project leaders in the current SPORE award and in this applicafion, as can be seen in
Table 1. The process that is in place will be used during the next funding period, as described below.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Profiling cancer neoantigen repertoires and validating immunotherapy targets
-
批准号:8865578
-
项目类别:
-
资助金额:$106.96万
-
财政年份:2013
-
负责人:MARTIN MCINTOSH
-
依托单位:
Profiling cancer neoantigen repertoires and validating immunotherapy targets
-
批准号:8656668
-
项目类别:
-
资助金额:$104.79万
-
财政年份:2013
-
负责人:MARTIN MCINTOSH
-
依托单位:
Profiling cancer neoantigen repertoires and validating immunotherapy targets
-
批准号:9070627
-
项目类别:
-
资助金额:$106.45万
-
财政年份:2013
-
负责人:MARTIN MCINTOSH
-
依托单位:
Profiling cancer neoantigen repertoires and validating immunotherapy targets
-
批准号:8495657
-
项目类别:
-
资助金额:$110.2万
-
财政年份:2013
-
负责人:MARTIN MCINTOSH
-
依托单位:
Biostatistics and Informatics Core
-
批准号:7727539
-
项目类别:
-
资助金额:$17.41万
-
财政年份:2009
-
负责人:MARTIN MCINTOSH
-
依托单位:
BIOMEDICAL (BASIC)
-
批准号:7938473
-
项目类别:
-
资助金额:$56.8万
-
财政年份:2009
-
负责人:MARTIN MCINTOSH
-
依托单位:
Affinity-based Seurm Proteomics: Breast/Ovarian Cancer
-
批准号:7280310
-
项目类别:
-
资助金额:$62.76万
-
财政年份:2005
-
负责人:MARTIN MCINTOSH
-
依托单位:
Affinity-Based Serum Proteomics: Breast and Ovarian Can*
-
批准号:7003892
-
项目类别:
-
资助金额:$52.76万
-
财政年份:2005
-
负责人:MARTIN MCINTOSH
-
依托单位:
Affinity-based Seurm Proteomics: Breast/Ovarian Cancer
-
批准号:7668583
-
项目类别:
-
资助金额:$54.32万
-
财政年份:2005
-
负责人:MARTIN MCINTOSH
-
依托单位:
Affinity-based Seurm Proteomics: Breast/Ovarian Cancer
-
批准号:7482483
-
项目类别:
-
资助金额:$65.85万
-
财政年份:2005
-
负责人:MARTIN MCINTOSH
-
依托单位:
Affinity-Based Serum Proteomics: Breast and Ovarian Can*
-
批准号:7118002
-
项目类别:
-
资助金额:$67.16万
-
财政年份:2005
-
负责人:MARTIN MCINTOSH
-
依托单位:
Affinity-Based Serum Proteomics: Breast and Ovarian Can*
-
批准号:7692033
-
项目类别:
-
资助金额:$17.6万
-
财政年份:2005
-
负责人:MARTIN MCINTOSH
-
依托单位:
Biomarkers for Ovarian Cancer Diagnosis and Screening
-
批准号:6989582
-
项目类别:
-
资助金额:$22.15万
-
财政年份:2004
-
负责人:MARTIN MCINTOSH
-
依托单位:
Biomarkers for Ovarian Cancer Diagnosis and Screening
-
批准号:7491204
-
项目类别:
-
资助金额:$12.48万
-
财政年份:--
-
负责人:MARTIN MCINTOSH
-
依托单位:
Developmental Research Program
-
批准号:8380136
-
项目类别:
-
资助金额:$6.66万
-
财政年份:--
-
负责人:MARTIN MCINTOSH
-
依托单位:
Biomarkers for Ovarian Cancer Diagnosis and Screening
-
批准号:7100992
-
项目类别:
-
资助金额:$22.69万
-
财政年份:--
-
负责人:MARTIN MCINTOSH
-
依托单位:
Biostatistics and Informatics Core
-
批准号:8380134
-
项目类别:
-
资助金额:$18.6万
-
财政年份:--
-
负责人:MARTIN MCINTOSH
-
依托单位:
Biostatistics and Informatics Core
-
批准号:8523024
-
项目类别:
-
资助金额:$21.15万
-
财政年份:--
-
负责人:MARTIN MCINTOSH
-
依托单位:
Developmental Research Program
-
批准号:8077362
-
项目类别:
-
资助金额:$6.82万
-
财政年份:--
-
负责人:MARTIN MCINTOSH
-
依托单位:
Molecular Profiling and Computational Biology (MPCB)
-
批准号:8520678
-
项目类别:
-
资助金额:$43.11万
-
财政年份:--
-
负责人:MARTIN MCINTOSH
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: